The new report by Expert Market Research titled, ‘United States Compounding Pharmacies Market Size Report and Forecast 2021-2026’, gives an in-depth analysis of United States compounding pharmacies market, assessing the market based on type, compounding type, sterility, distribution channel, application and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Request a free sample copy in PDF or view the report [email protected] https://www.expertmarketresearch.com/reports/united-states-compounding-pharmacies-market/requestsample
The key highlights of the report include:
Market Overview (2016-2026)
- Forecast CAGR (2021-2026): 6%
COVID-19 increases the necessity for compounded pharmacies around the country. The FDA has authorized drug compounding for certain critically ill patients in hospitals due to the growing demand for medications. According to the U.S. FDA, there may not be enough FDA-approved medicines and medicines compounded by outsourcing facilities to treat all hospitalized patients.
Industry Definition and Major Segments
A compounding pharmacy is a pharmacy that is operated by a licensed pharmacist, a licensed physician, or a person who works under the supervision of a licensed pharmacist.
Based on type, the market is divided into:
With regards to compounding type, the market is segmented into:
- Pharmaceutical Ingredient Alteration (PIA)
- Currently Unavailable Pharmaceutical Manufacturing (CUPM)
- Pharmaceutical Dosage Alteration (PDA)
On the basis of sterility, the market is bifurcated into:
By therapeutic area, the market is segregated into:
- Pain and Management
- Hormone Replacement Therapy (HRT)
Based on distribution channel, the market is segmented into:
- Hospital Pharmacies
- Retail Pharmacies
By application, the market is segmented into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Geriatric population growth and extended life expectancy will be the key growth driver. Elderly population in the U.S. is predicted to account for 24% of the overall population by the year 2060. There has been a significant decrease in fertility rate and increase in life expectancy. Additionally, inexpensive rates of compounding pharmacies proved helpful for the overall sector expansion. There is a higher proportion of people who are predisposed to compound pharmacies and demand for anti-aging products has increased, which favours the market share. Safety requirements may effect market demand.
Canavan disease is inherited, which means it’s passed down from parents to children.A mutation in a gene that makes an enzyme called aspartoacylase (ASPA) causes the disease. ASPA’s job is to break down a brain chemical called N-acetyl-aspartate (NAA).
People with Canavan disease don’t have enough ASPA, so NAA builds up in brain tissue. This damages their myelin (white matter), a fatty substance that protects and nourishes nerves in their brain and spine. Over time, this causes their brain to deteriorate into spongy tissue with lots of tiny fluid-filled spaces. It also prevents their brain from sending and receiving nerve signals properly.
The growing drug shortages will affect the size of the market. Drugs may not be available due to several reasons, such as problems of manufacture, stoppage of drugs due to interruptions and reduced use in the supply chain. The segment’s income will be fostered by the increased number of chronic disorders requiring emergency medicine and increasing drug deficiencies.
Key Market Players
The major players in the market are Fagron N.V., PharMedium Services, LLC, Fresenius Kabi Canada and among others. The report covers the market shares, capacities, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Alice Addy, Business Consultant
Email: [email protected]
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.